Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA)
BRL 8.73
(-0.46%)
BRL 8.73
(-0.46%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.9 Billion BRL | 17.22% |
| 2022 | 1.62 Billion BRL | 21.73% |
| 2021 | 1.33 Billion BRL | 12.77% |
| 2020 | 1.18 Billion BRL | 26.45% |
| 2019 | 936.1 Million BRL | 74.5% |
| 2018 | 536.46 Million BRL | 2.49% |
| 2017 | 523.42 Million BRL | 19.14% |
| 2016 | 439.32 Million BRL | 5.65% |
| 2015 | 415.82 Million BRL | 1.93% |
| 2014 | 407.96 Million BRL | 26.31% |
| 2013 | 322.99 Million BRL | 20.89% |
| 2012 | 267.17 Million BRL | 9.99% |
| 2011 | 242.91 Million BRL | 19.03% |
| 2010 | 204.07 Million BRL | 11.83% |
| 2009 | 182.48 Million BRL | 25.9% |
| 2008 | 144.94 Million BRL | 13.17% |
| 2007 | 128.07 Million BRL | 9.89% |
| 2006 | 116.55 Million BRL | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.97 Billion BRL | -1.61% |
| 2024 Q1 | 2 Billion BRL | 5.43% |
| 2023 FY | 1.9 Billion BRL | 17.22% |
| 2023 Q1 | 1.68 Billion BRL | 3.99% |
| 2023 Q2 | 1.65 Billion BRL | -1.89% |
| 2023 Q3 | 1.8 Billion BRL | 8.97% |
| 2023 Q4 | 1.9 Billion BRL | 5.44% |
| 2022 Q2 | 1.42 Billion BRL | 0.68% |
| 2022 Q1 | 1.41 Billion BRL | 6.04% |
| 2022 FY | 1.62 Billion BRL | 21.73% |
| 2022 Q3 | 1.47 Billion BRL | 3.75% |
| 2022 Q4 | 1.62 Billion BRL | 9.9% |
| 2021 Q4 | 1.33 Billion BRL | 9.01% |
| 2021 Q1 | 1.23 Billion BRL | 4.52% |
| 2021 Q2 | 1.11 Billion BRL | -9.71% |
| 2021 Q3 | 1.22 Billion BRL | 9.6% |
| 2021 FY | 1.33 Billion BRL | 12.77% |
| 2020 Q4 | 1.18 Billion BRL | 0.94% |
| 2020 FY | 1.18 Billion BRL | 26.45% |
| 2020 Q3 | 1.17 Billion BRL | 16.32% |
| 2020 Q2 | 1 Billion BRL | -4.34% |
| 2020 Q1 | 1.05 Billion BRL | 12.59% |
| 2019 Q1 | 729 Million BRL | 35.89% |
| 2019 FY | 936.1 Million BRL | 74.5% |
| 2019 Q2 | 803.9 Million BRL | 10.27% |
| 2019 Q3 | 853.93 Million BRL | 6.22% |
| 2019 Q4 | 936.1 Million BRL | 9.62% |
| 2018 Q1 | 447.4 Million BRL | -14.52% |
| 2018 Q4 | 536.46 Million BRL | 6.85% |
| 2018 Q3 | 502.06 Million BRL | 4.66% |
| 2018 Q2 | 479.73 Million BRL | 7.22% |
| 2018 FY | 536.46 Million BRL | 2.49% |
| 2017 Q1 | 380.49 Million BRL | -13.39% |
| 2017 FY | 523.42 Million BRL | 19.14% |
| 2017 Q4 | 523.42 Million BRL | 25.99% |
| 2017 Q3 | 415.44 Million BRL | 0.34% |
| 2017 Q2 | 414.03 Million BRL | 8.82% |
| 2016 Q2 | 415.25 Million BRL | 7.29% |
| 2016 Q4 | 439.32 Million BRL | 14.13% |
| 2016 Q3 | 384.92 Million BRL | -7.3% |
| 2016 Q1 | 387.05 Million BRL | -6.92% |
| 2016 FY | 439.32 Million BRL | 5.65% |
| 2015 Q1 | 360.59 Million BRL | -11.61% |
| 2015 Q3 | 374.39 Million BRL | -0.38% |
| 2015 FY | 415.82 Million BRL | 1.93% |
| 2015 Q4 | 415.82 Million BRL | 11.07% |
| 2015 Q2 | 375.82 Million BRL | 4.22% |
| 2014 Q3 | 365.2 Million BRL | 8.26% |
| 2014 Q4 | 407.96 Million BRL | 11.71% |
| 2014 FY | 407.96 Million BRL | 26.31% |
| 2014 Q2 | 337.32 Million BRL | 16.26% |
| 2014 Q1 | 290.15 Million BRL | -10.17% |
| 2013 Q3 | 310.01 Million BRL | 14.21% |
| 2013 Q1 | 270.16 Million BRL | 1.12% |
| 2013 FY | 322.99 Million BRL | 20.89% |
| 2013 Q4 | 322.99 Million BRL | 4.19% |
| 2013 Q2 | 271.43 Million BRL | 0.47% |
| 2012 FY | 267.17 Million BRL | 9.99% |
| 2012 Q4 | 267.17 Million BRL | 0.0% |
| 2011 FY | 242.91 Million BRL | 19.03% |
| 2010 FY | 204.07 Million BRL | 11.83% |
| 2009 FY | 182.48 Million BRL | 25.9% |
| 2008 FY | 144.94 Million BRL | 13.17% |
| 2007 FY | 128.07 Million BRL | 9.89% |
| 2006 FY | 116.55 Million BRL | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|